Débora de Souza Ferreira Sávio

Ms. Débora de Souza Ferreira Sávio

orcid

Research Focus & Metrics

Representative Publications

View All Publications
6 July 2023 in Platelets
Verified
Journal Article
Open access
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
LSLucia Moitrel Pequeno Da Silva
Lucia Moitrel Pequeno Da Silva
GRGabriel Guerra David Reis
Gabriel Guerra David Reis
RDRicardo Junior Denardi
Ricardo Junior Denardi
NCNatacha Costa
Natacha Costa
MMMichel Reis Messora
Michel Reis Messora
This study evaluated the potential of Leukocyte-platelet-rich fibrin (L-PRF; fixed angle centrifugation protocol), Advanced-platelet-rich fibrin (A-PRF; low-speed fixed angle centrifugation protocol), and Horizontal-platelet-rich fibrin (H-PRF; horizontal centrifugation protocol) in bone neoformation in critical size defects (CSDs) in rat calvaria. Thirty-two rats were divided into groups: Control (C), L-PRF, A-PRF, and H-PRF. 5 mm diameter CSDs were created in the animals' calvaria. Defects from group Control (C) were filled with blood clots, while defects from groups L-PRF, A-PRF, and H-PRF were filled with respective platelet-rich fibrin (PRF) membranes. L-PRF, A-PRF, and H-PRF were prepared from animal blood collection and specific centrifugation protocols. At 14 and 30 days, calcein (CA) and alizarin (AL) injections were performed, respectively. Animals were euthanized at 35 days. Microtomographic, laser confocal microscopy, and histomorphometric analyzes were performed. Data were statistically analyzed (ANOVA, Tukey, p < .05). L-PRF, A-PRF, and H-PRF groups showed higher values of bone volume (BV), newly formed bone area (NFBA), and precipitation of CA and AL than the C group (p < .05). The H-PRF group showed higher values of BV, number of trabeculae (Tb. N), NFBA, and higher precipitation of AL than the A-PRF and L-PRF groups (p < .05). Therefore, it can be concluded that: i) L-PRF, A-PRF, and H-PRF potentiate bone neoformation in CSDs in rat calvaria; ii) H-PRF demonstrated more biological potential for bone healing.

19 May 2022 in Platelets
Verified
Journal Article
Closed access
LSLucia Moitrel Pequeno Da Silva
Lucia Moitrel Pequeno Da Silva
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
FÁFelipe Correa de Ávila
Felipe Correa de Ávila
RVRaphael Martini Vicente
Raphael Martini Vicente
GRGabriel Guerra David Reis
Gabriel Guerra David Reis
MMMichel Reis Messora
Michel Reis Messora
The current study evaluated the healing of critical-size defects (CSD) created in rat calvaria treated with platelet concentrates produced by high-speed (Leukocyte- and Platelet-Rich Fibrin - L-PRF) and low-speed (Advanced Platelet-Rich Fibrin - A-PRF) protocols of centrifugation. Twenty-four rats were distributed into three groups: Control, L-PRF, and A-PRF. Five mm diameter CSD were created on the animals’ calvaria. The defects of the L-PRF and A-PRF groups were filled with 0.01 ml of L-PRF and A-PRF, respectively. The control group defects were filled with a blood clot only. All animals were euthanized on the 35th postoperative day. Histomorphometric and microtomographic analyses were then performed. The L-PRF and A-PRF groups had significantly higher bone volume and neoformed bone area than those of the control group and lowered bone porosity values (p < .05). No significant differences were observed between A-PRF and L-PRF groups for the analyzed parameters. Therefore, it can be concluded that i) L-PRF and A-PRF potentiated the healing of CSD in rat calvaria; ii) high and low-speed centrifugation protocols did not produce PRF matrices with different biological impacts on the amount of bone neoformation.

11 November 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FFFlavia Furlaneto
Flavia Furlaneto
YLYara Loyanne de Almeida Silva Levi
Yara Loyanne de Almeida Silva Levi
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
ISIzadora Cianfa Firmino da Silveira
Izadora Cianfa Firmino da Silveira
AOAdriana Miranda de Oliveira
Adriana Miranda de Oliveira
MMMichel Reis Messora
Michel Reis Messora
Objective: To evaluate the adjunctive use of the probiotic Bifidobacterium animalis subsp. lactis HN019 (B. lactis HN019) to conventional therapy on clinical and microbiological parameters in patients with generalized gingivitis. Methods: Sixty systemically healthy individuals with untreated generalized gingivitis were submitted to periodontal therapy and allocated to receive Placebo (n = 30) or Probiotic (n = 30) lozenges, twice a day for 8 weeks. Bleeding on Marginal Probing (BOMP) was evaluated at baseline, after 2 and 8 weeks. Supra and subgingival biofilm were obtained at baseline and 8 weeks post-therapy for analyses by 16S rRNA gene sequencing. Differences between therapeutic groups were analyzed by non-parametric tests (p<0.05). Results: The Placebo and Probiotic groups showed a significant reduction in BOMP at 8 weeks compared to baseline (p<0.05). The Probiotic group had a lower percentage of BOMP when compared with the Placebo group at 8 weeks (p<0.0001). Alpha and beta-diversity showed no statistical significance between groups and time points. At phylum level, no significant differences were observed between groups and time points. At genus level, an increase in the relative abundances of Bergeyella and Corynebacterium were significantly associated with a greater reduction in bleeding in the Placebo group and with less reduction in bleeding in the Probiotic group, respectively. At species level, Schaalia spp., Streptococcus gordonii, and Leptotrichia wadei increased in Placebo and decreased in the Probiotic group after treatment. Granulicatella adiacens decreased significantly after the probiotic therapy, while Saccharibacteria (TM7) spp., Solobacterium moorei, and Catonella morbi increased significantly. In the Placebo group, Bergeyella sp. HMT-322 was associated with a greater percentage of reduction in bleeding. In both groups, Actinomyces species were related to less reduction in bleeding. Conclusion: The adjuvant use of B. lactis HN019 alongside conventional therapy enhanced the reduction in BOMP and promoted greater changes in the microbiological profile of patients with generalized gingivitis. Trial registration: The study was registered at Brazilian Clinical Trials Registry (ReBEC; protocol number: RBR-59v2yb).

18 June 2026 in Clinical Advances in Periodontics
Verified
Journal Article
Open access
PDF file
EVEdgar Daniel Vargas‐Quiroga
Edgar Daniel Vargas‐Quiroga
AFAna Carolina Duarte Firmino
Ana Carolina Duarte Firmino
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
RBRhayssa Tritula Barini
Rhayssa Tritula Barini
JFJuliana Jendiroba Faraoni
Juliana Jendiroba Faraoni
ANARTHUR B. NOVAES
ARTHUR B. NOVAES
Background: This case report describes 18‐month clinical and digital outcomes after bilateral treatment of multiple gingival recessions using coronally advanced flap plus acellular dermal matrix (ADM). Methods: A 46‐year‐old woman with multiple maxillary recessions received bilateral surgery. Outcomes at baseline (BL), 6 months (6M), 12 months (12M), and 18 months (18M) included recession depth, recession width, keratinized tissue width, and gingival thickness. Intraoral scans were taken at all visits. Standard Tessellation Language (STL) models were superimposed per hemiarch using baseline‐referenced and remodeling‐interval analyses. Digital metrics included root mean square (RMS) and average positive and negative deviations for each interval. Results: At 6M, the left side achieved complete root coverage, with partial recurrence at teeth #13 and #14 at 12 and 18M. On the right, teeth #6 and #3 improved and remained stable. At tooth #4, limited dehiscence with partial ADM exposure occurred at 1 week without infection. Loose sutures were removed, and 0.12% chlorhexidine gauze cleansing without rinsing was prescribed until epithelial closure. Conservative care led to progressive re‐epithelialization and complete closure by 1 month, with stable integration at 18M. Digital analysis showed higher RMS values on the right in baseline‐referenced comparisons (BL – 6M, BL – 12M, and BL – 18M) and remodeling intervals (6M–12M, 12M–18M, and 6M–18M), indicating greater surface deviation on the right side during follow‐up. Conclusions: Both sides showed favorable evolution but different healing trajectories. Serial STL superimposition documented tissue remodeling and post‐exposure healing, supporting its use as a complementary tool for mucogingival follow‐up. In this case, the site with early ADM exposure showed gradual healing after conservative management. Key points: Early acellular dermal matrix exposure may heal when there are no signs of infection and follow‐up is strict. Serial superimposition of intraoral scans adds side‐specific information that complements routine clinical assessment. Plain language summary: This report presents a patient with bilateral maxillary gingival recessions, treated with the same surgical technique and a soft‐tissue substitute. One side healed uneventfully. On the other side, there was an early wound opening with partial matrix exposure; the area closed progressively and was fully covered by 1 month, with stability at 18 months. Clinical measurements and serial 3D intraoral scans showed improvement on both sides. However, the two sides showed different remodeling patterns over time. The patient was satisfied with the outcome, although cervical restoration was required in the tooth with exposure. The exposed matrix area closed progressively without the need for additional surgery.

7 August 2026 in Oral and Maxillofacial Surgery
Verified
Journal Article
Open access
PDF file
EVEdgar Daniel Vargas-Quiroga
Edgar Daniel Vargas-Quiroga
BPBrenda Carolina Pattigno-Forero
Brenda Carolina Pattigno-Forero
AFAna Carolina Duarte Firmino
Ana Carolina Duarte Firmino
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
Carolina Alves Freiria de OliveiraCarolina Alves Freiria de Oliveira
Carolina Alves Freiria de Oliveira
ANARTHUR B. NOVAES
ARTHUR B. NOVAES
Purpose: To summarize the available clinical evidence on biological adjuncts in tooth autotransplantation, including adjunct types, application protocols, procedural variables, reported outcomes, and evidence gaps. Methods: This scoping review followed JBI guidance and PRISMA-ScR. PubMed/MEDLINE, Embase, Web of Science, Scopus, and LILACS were searched from inception to 21 June 2026. Clinical human studies reporting tooth autotransplantation with at least one biologic adjunct and clinical or radiographic outcomes were included. Data were charted for study characteristics, population, autotransplanted teeth, adjunct type and application protocol, follow-up, and key findings. Critical appraisal was performed using design-specific tools. Results: Twenty-two sources published between 2005 and 2026 were included, comprising 234 patients and 257 autotransplanted teeth. Most evidence came from case reports and case series, with few comparative clinical studies. Platelet-derived preparations were the most frequently reported adjuncts, including L-PRF, A-PRF, PRP, PRGF, and CGF. Enamel matrix derivative was also reported, mainly as a root-surface application. Most studies described favorable clinical and radiographic outcomes, but protocols, root maturity, recipient-site conditions, stabilization, endodontic strategies, follow-up schedules, and outcome definitions were highly heterogeneous. Comparative and retrospective studies had serious risk of bias, mainly due to confounding. Conclusion: Biological adjuncts in tooth autotransplantation have demonstrated clinical feasibility in selected reports, but current evidence is insufficient to establish their independent benefit or superiority over standard protocols. Root maturity and procedural variables appear to be more consistent determinants of outcomes and should guide interpretation.

16 October 2026 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
WBWanderson Thalles de Souza Braga
Wanderson Thalles de Souza Braga
UMUlli da Costa Cunha Martins
Ulli da Costa Cunha Martins
DSDébora de Souza Ferreira Sávio
Débora de Souza Ferreira Sávio
LSLucia Moitrel Pequeno Da Silva
Lucia Moitrel Pequeno Da Silva
MSMaria da Conceição Pereira Saraiva
Maria da Conceição Pereira Saraiva
MMMichel Reis Messora
Michel Reis Messora
Background: This study assessed the impact of xenogeneic bone grafts (XEN), either utilized alone or combined with autologous platelet concentrates (APCs) prepared using three different centrifugation protocols, on the healing of critical-size defects (CSDs) in rat calvaria. Methods: Forty rats were assigned to five groups (n = 8): Control, XEN, XEN + L-PRF, XEN + A-PRF, and XEN + Bio-PRF. Blood concentrates were prepared by centrifuging blood collected via cardiac puncture: L-PRF (~700 g for 12 min), A-PRF (~208 g for 14 min), and Bio-PRF (~700 g for 8 min). Defects (5 mm diameter) in the right parietal bone of each rat were filled with blood clot, XEN, or XEN combined with L-PRF, A-PRF, or Bio-PRF. Animals were euthanized 60 days post-surgery, and the calvariae were analyzed using histomorphometry and micro-CT. The percentage of mature and immature collagen fibers was analyzed using Picrosirius red staining under polarized light microscopy. Results: Groups XEN-A-PRF, XEN-L-PRF, and XEN-Bio-PRF presented higher bone volume (BV/TV) than the control group (14.35 ± 6.42%, 11.96 ± 4.68%, and 14.92 ± 3.47%, respectively, vs. 4.13 ± 2.25%; p < 0.05). These groups also presented lower bone porosity (BP) than the control group (p < 0.05). The XEN group did not show different values of BV/TV and BP compared to the control group. Only the XEN + A-PRF and XEN + Bio-PRF groups showed a higher percentage of mature collagen fibers (red color) compared to the XEN and control groups (p < 0.05). The control and XEN groups showed a higher amount of immature collagen fibers (green color) compared to the XEN + A-PRF, XEN + L-PRF, and XEN + Bio-PRF groups (p < 0.05). Conclusions: It can be concluded that CSDs treated with XEN combined with APCs presented a more favorable bone microarchitecture than untreated CSDs after a 60-day healing period. Furthermore, CSDs treated with XEN combined with A-PRF or Bio-PRF showed greater collagen maturation than those treated with XEN alone, suggesting that the centrifugation protocol used for preparing APCs may be a decisive factor for the quality of the collagen matrix in newly formed bone tissue.